Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Chronic liver diseases (CLDs) encompass a wide range of illnesses, including nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and viral hepatitis. Deterioration of liver capacity, with subsequent progression into cirrhosis and hepatocellular carcinoma (HCC), ultimately leads to a furt...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Hepatocell Carcinoma
Glavni autori: Abdel-Wahab, Reham, Shehata, Samir, Hassan, Manal M, Habra, Mouhammed A, Eskandari, Ghazaleh, Tinkey, Peggy T, Mitchell, Jennifer, Lee, Ju-Seog, Amin, Hesham M, Kaseb, Ahmed O
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918293/
https://ncbi.nlm.nih.gov/pubmed/27508202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S81309
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items